TICAM1 inhibits angiogenesis and accelerates inflammation in the healing of diabetic wounds via the NF-κB pathway

Key Points

• Inhibition of angiogenesis was observed alongside accelerated inflammation, affecting wound healing processes.
• Key evidence shows a significant correlation between TICAM1 levels and enhanced inflammatory responses in diabetic wounds.
• Analysis focused on the NF-κB pathway, revealing its role in mediating the effects of TICAM1 on angiogenesis and inflammation.
• Highlights the need for further investigation into TICAM1's dual role in wound healing and potential therapeutic avenues.